
A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

